Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members: Protocol for an Interventional Cohort Study in 2020-2021

NCT04813497 is registered in ClinicalTrials.gov with Grand Hôpital de Charleroi as lead sponsor.

NCT NCT04813497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04813497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members: Protocol for an Interventional Cohort Study in 2020-2021
Lead sponsor
Grand Hôpital de Charleroi
Phase
Not applicable
Overall status
Completed
Start date
February 5, 2021
Completion date
April 30, 2022
Enrollment
4,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19